When Psychiatry Is Not Primary: A Rare Prion Disease Unmasked

Neurodegenerative diseases presenting with predominant psychiatric symptoms remain a diagnostic challenge, particularly in younger patients. This case report highlights an uncommon but critical diagnostic consideration—Gerstmann–Sträussler–Scheinker (GSS) disease, a rare inherited prion disorder.
When Psychiatry Is Not Primary: A Rare Prion Disease Unmasked
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Explore the Research

BioMed Central
BioMed Central BioMed Central

Psychiatric presentation of Gerstmann–Sträussler–Scheinker disease with 9-OPRI mutation in PRNP gene: a case report - Journal of Medical Case Reports

Background Gerstmann–Sträussler–Scheinker syndrome is an extremely rare autosomal-dominant neurodegenerative disease that presents with a broad spectrum of neurological and psychiatric symptoms. Systematic case reports, which document genetic mutations and phenotypic variations, are a significant contribution to improving the diagnosis and approach of these rare diseases. Case report presentation A 42-year-old White woman with a confirmed diagnosis of Gerstmann–Sträussler–Scheinker syndrome was admitted to the psychiatry department due to severe confusion and episodes of agitation. The patient had been experiencing marked irritability and daytime restlessness, as well as severe insomnia that resulted in nocturnal falls. She exhibited fluctuating stereotypical behavior and disorientation, failing to recognize her husband and child. The aim of the psychiatric intervention was to enhance the patient’s quality of life by alleviating acute psychiatric symptoms through pharmacological treatment. Following successful adjustment of medication, the patient was discharged from inpatient treatment after approximately 1 month, demonstrating marked improvement in her clinical condition. However, 3 months later, she was readmitted to the hospital with progression of symptoms, including sleep disturbance, agitation, gait instability, and severe imbalance, which led to recurrent falls. She also developed dysarthria, which substantially impaired her verbal communication. The progressive neurodegenerative course of her illness ultimately necessitated extensive support from her family at home, imposing considerable emotional, physical, and financial strain on the caregivers. A collaborative approach with the neuropalliative care team was initiated to optimize symptom management and to develop individualized models of care. Conclusion The patient presented with atypical and intermittent speech disturbances, tremors, and bradykinesia, which were initially misdiagnosed as conversion disorder. A positive family history prompted PRNP genetic testing, leading to the definitive diagnosis of Gerstmann–Sträussler–Scheinker syndrome. The management of cases in patients with incurable prion diseases poses distinct challenges, including unpredictable clinical progression and highly individualized symptom trajectories. A multidisciplinary approach is essential to address psychiatric manifestations, navigate legal and ethical considerations, and ensure comprehensive professional care. The development of adaptable care models that respond to the complex needs of these rare conditions remains a critical priority.

Case Overview

A 42-year-old woman presented with progressive confusion, agitation, insomnia, and behavioral disturbances, ultimately requiring psychiatric hospitalization. Early symptoms included tremor, dysarthria, and psychomotor slowing, which were initially attributed to conversion disorder.

Over time, the clinical picture evolved to include:

Progressive cognitive decline
Gait instability and recurrent falls
Dysarthria and impaired communication
Emotional lability and severe sleep disturbance

A key turning point was recognition of a positive family history, prompting genetic testing. This confirmed a 9-octapeptide repeat insertion (9-OPRI) mutation in the PRNP gene, establishing the diagnosis of GSS .

Why This Case Matters

This case underscores several critical clinical principles:

Psychiatric-first presentations are common in prion disease—reported in up to 87% of cases
Misdiagnosis is frequent, particularly as functional or primary psychiatric disorders
Standard neurodiagnostics (MRI, EEG, CSF) may be nondiagnostic early
Family history remains pivotal in triggering appropriate genetic evaluation

Notably, the 9-OPRI mutation is exceptionally rare, with only a handful of reported cases worldwide .

Management Challenges

There is no disease-modifying therapy for GSS. Management is therefore centered on:

Symptom-directed pharmacologic therapy (e.g., antipsychotics, antidepressants, sleep agents)
Structured psychiatric and nursing care
Fall prevention and environmental adaptation
Early integration of neuropalliative care

This case also highlights the substantial caregiver burden, requiring coordinated multidisciplinary support.

Clinical Pearl

In younger patients with atypical psychiatric syndromes—especially with progressive neurological features or family history—consider prion disease and pursue genetic testing earlier.

Question

Which feature should most strongly prompt reconsideration of a primary psychiatric diagnosis in this context?

A. Acute onset insomnia
B. Emotional lability
C. Progressive neurological decline with family history
D. Response to antipsychotics

Answer: C

The combination of progressive neurological deterioration and a positive family history is a red flag for underlying neurodegenerative or genetic disease, warranting targeted testing such as PRNP analysis.

Closing Perspective

This case is a powerful reminder that not all psychiatric presentations are psychiatric in origin. As neurologists and clinicians, maintaining diagnostic vigilance—particularly in atypical, progressive, or familial cases—remains essential.

Rare diseases such as GSS, while uncommon, offer profound insights into neurodegeneration, diagnostic reasoning, and the importance of integrated neurologic and psychiatric care.

Journal of Medical Case Reports is the world’s first international, PubMed-listed, medical journal devoted to publishing case reports from all medical disciplines and will consider any original case report that expands the field of general medical knowledge, and original research relating to case reports.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in